US20070287670A1 - Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions - Google Patents

Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions Download PDF

Info

Publication number
US20070287670A1
US20070287670A1 US11/740,031 US74003107A US2007287670A1 US 20070287670 A1 US20070287670 A1 US 20070287670A1 US 74003107 A US74003107 A US 74003107A US 2007287670 A1 US2007287670 A1 US 2007287670A1
Authority
US
United States
Prior art keywords
bip
phe
alkyl
di
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/740,031
Inventor
Sesha Natarajan
Claudio Mapelli
Margarita Bastos
Michael Bernatowicz
Ving Lee
William Ewing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US34201501P priority Critical
Priority to US10/273,975 priority patent/US7238670B2/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23339970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20070287670(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to US11/740,031 priority patent/US20070287670A1/en
Publication of US20070287670A1 publication Critical patent/US20070287670A1/en
Application status is Abandoned legal-status Critical

Links